NCT05003947View on ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 11, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Inflammatory Bowel Diseases
Interventions
BIOLOGICAL

AlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells

Trial Locations (2)

Unknown

RECRUITING

Medical Surgical Associates Center, St John's

RECRUITING

Center for Investigation in Tissue Engineering and Cellular Therapy, Buenos Aires

All Listed Sponsors
lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER